Rau Joseph L, Coppolo Dominic P, Nagel Mark W, Avvakoumova Valentina I, Doyle Cathy C, Wiersema Kimberly J, Mitchell Jolyon P
Cardiopulmonary Care Sciences, Georgia State University, Atlanta, Georgia 30084, USA.
Respir Care. 2006 May;51(5):503-10.
Electrostatic attraction of aerosolized particles to the inner walls of an aerosol holding chamber (HC) made from a nonconducting material can reduce medication delivery, particularly if there is a delay between actuation and inhalation.
Compare total emitted mass and fine-particle mass (mass of particles < 4.7 microm) of hydrofluoroalkane-propelled albuterol from similar-sized HCs manufactured from conductive material (Vortex), charge-dissipative material (AeroChamber Max), and nonconductive material (OptiChamber Advantage, ProChamber, Breathrite, PocketChamber, and ACE), with and without wash/rinse pretreatment of the HC interior with ionic detergent, and with 2-s and 5-s delays between actuation and inhalation.
All the HCs were evaluated (1) directly from their packaging (with no wash/rinse pretreatment) and (2) after washing with ionic detergent and rinsing and drip-drying. We used an apparatus that interfaced between the HC mouthpiece and the induction port of an 8-stage Andersen cascade impactor to simulate a poorly coordinated patient, with delays of 2 s and 5 s between actuation and inhalation/sampling, at 28.3 L/min.
With the 2-s delay, the delivered fine-particle mass per actuation, before and after (respectively) wash/rinse pretreatment was: AeroChamber Max: 23.8 +/- 4.8 microg, 21.5 +/- 3.2 microg; Vortex: 16.2 +/- 1.7 microg, 15.5 +/- 2.0 microg; OptiChamber Advantage: 2.6 +/- 1.2 microg, 6.7 +/- 2.3 microg; ProChamber: 1.6 +/- 0.4 microg, 5.1 +/- 2.5 microg; Breathrite: 2.0 +/- 0.9 microg, 3.2 +/- 1.8 microg; PocketChamber: 3.4 +/- 1.6 microg, 1.7 +/- 1.6 microg; ACE: 4.5 +/- 0.9 microg, 5.4 +/- 2.9 microg. Similar trends, but greater reduction in aerosol delivery, were observed with the 5-s delay. Significantly greater fine-particle mass was delivered from HCs made from conducting or charge-dissipative materials than from those made from nonconductive polymers, even after wash/rinse pretreatment (p < 0.01). The fine-particle mass was also significantly greater from the AeroChamber Max than from the Vortex, irrespective of wash/rinse pretreatment or delay interval (p < 0.01).
HCs made from electrically conductive materials emit significantly greater fine-particle mass, with either a 2-s or 5-s delay, than do HCs made from nonconducting materials, even with wash/rinse pretreatment.
雾化颗粒对由非导电材料制成的气雾剂储存罐(HC)内壁的静电吸引会减少药物递送,尤其是在启动和吸入之间存在延迟的情况下。
比较由导电材料(Vortex)、电荷耗散材料(AeroChamber Max)和非导电材料(OptiChamber Advantage、ProChamber、Breathrite、PocketChamber和ACE)制成的类似尺寸的HC,在对HC内部进行离子洗涤剂清洗/冲洗预处理前后,以及在启动和吸入之间有2秒和5秒延迟的情况下,氢氟烷烃推进的沙丁胺醇的总喷出质量和细颗粒质量(颗粒直径<4.7微米的质量)。
所有的HC均进行评估:(1)直接从其包装中取出(未进行清洗/冲洗预处理);(2)用离子洗涤剂清洗、冲洗并滴干后进行评估。我们使用一种连接HC吸嘴和八级安德森级联撞击器进气口的装置,以模拟配合不佳的患者,在启动和吸入/采样之间有2秒和5秒的延迟,流速为28.3升/分钟。
在2秒延迟的情况下,清洗/冲洗预处理前后每次启动的细颗粒递送质量分别为:AeroChamber Max:23.8±4.8微克,21.5±3.2微克;Vortex:16.2±1.7微克,15.5±2.0微克;OptiChamber Advantage:2.6±1.2微克,6.7±2.3微克;ProChamber:1.6±0.4微克,5.1±2.5微克;Breathrite:2.0±0.9微克,3.2±1.8微克;PocketChamber:3.4±1.6微克,1.7±1.6微克;ACE:4.5±0.9微克,5.4±2.9微克。在5秒延迟的情况下观察到类似趋势,但气雾剂递送减少得更多。即使在清洗/冲洗预处理后,由导电或电荷耗散材料制成的HC递送的细颗粒质量也显著高于由非导电聚合物制成的HC(p<0.01)。无论清洗/冲洗预处理或延迟间隔如何,AeroChamber Max递送的细颗粒质量也显著高于Vortex(p<0.01)。
即使经过清洗/冲洗预处理,由导电材料制成的HC在2秒或5秒延迟的情况下,比由非导电材料制成的HC喷出的细颗粒质量显著更高。